Clinical Trials Browser

Phase 2 × Microsatellite Instability × Immunoglobulin G × Clear all

NCT02966587 2018-01-17

Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Withdrawn

Microsatellite Instability